One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

Press Release4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral ...

Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral ImmunotherapyCompany founded by 4BIO Capital and ...

"By combining our deep expertise in advanced therapies with the company's breakthrough science, we've helped shape a platform with the potential to fundamentally change cancer treatment. The ...

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency.

With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an ...

An experimental vaccine showed promise in treating aggressive breast cancer, while a new gene therapy method advances ...

Bacteria are helping to enhance the body's immune system's ability to attack cancer cells. This phenomenon is paving the way ...

As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

Nuvectis Pharma (NVCT) stock falls as company posts interim data from a Phase 1b trial for its ovarian cancer drug candidate.

Researchers have created a groundbreaking antibody that combines targeting, delivery, and immune activation to treat cancer, ...